Portfolio Manager Factsheet
July proved to be a strong month for global healthcare equity returns. Second quarter earnings, for the most part, exceeded expectations, particularly for large cap pharmaceutical stocks, further stoking a momentum trade that commenced earlier in the month. Emerging market healthcare share prices were weak in the month. Specifically, the China stock market reacted negatively to the worsening U.S./China trade tension and the sharp depreciation of Chinese currency.
Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.